Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 22 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Omeprazole Omeprazole is a proton pump inhibitor that blocks H(+)-K(+)-ATPase , used to treat dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome.
In vitro
Omeprazole potently induces cytochrome P4501A1 mRNA expression in primary human hepatocytes, whereas this effect is not detected in mouse primary hepatocytes. Omeprazole induces transcription of reporter genes via the xenobiotic response element that is recognized by the ligand-activated dioxin receptor in human hepatoma cells. Omeprazole causes a strong inhibition of basal natural killer (NK) activity in spleen cells (SC) from untreated CD2F1 mice. Omeprazole causes a rapid, strong effect on various types of cytotoxic lymphocytes ranging from cytotoxicity inhibition to irreversible cell damage. Omeprazole induces a significant inhibition of cytotoxic activity of all types of effector cells after 30 min incubation. Omeprazole decreases the activation ofosteoclasts but increases that of osteoblasts in vitro, in part causing an osteopetrosis-like effect.
In vivo
Cell Data
cell lines:HOS, HTB-186 Daoy, TC-71, RD, SK-N-AS, SK-N-DZ, LD and KCNR cells
Concentrations:
Incubation Time:
Powder Purity:≥95%
| Isómeros SMILES | CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC |
|---|---|
| WGK Alemania | 2 |
| RTECS | DD9087000 |
| Peso molecular | 345.42 |
| Reaxy-Rn | 6489199 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=6489199&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Punto de fusión (°C) | 158-159°C |
|---|
| 1. Renhao Ni, Yang Luo, Lingjing Jiang, Xufeng Mao, Yuyao Feng, Subinuer Tuersun, Zeming Hu, Yabin Zhu. (2023) Repairing gastric ulcer with hyaluronic acid/extracellular matrix composite through promoting M2-type polarization of macrophages. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, [PMID:37364804] [10.1016/j.ijbiomac.2023.125556] |
| 2. Yanxia Liu, Wei Du, Xiuquan Yao, Chunlin Liu, Xiaofang Luo, Lei Guo, Chao Guo. (2023) Electrochemical and Theoretical Study of Corrosion Inhibition on X60 Steel in H2SO4 Solution by Omeprazole. International Journal of Electrochemical Science, [PMID:] [10.20964/2022.04.58] |
| 3. Shasha Liu, Ruohan Cheng, Hui He, Kunming Ding, Rongmi Zhang, Yuanyuan Chai, Qinwei Yu, Xin Huang, Luyong Zhang, Zhenzhou Jiang. (2023) 8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, [PMID:37121295] [10.1016/j.abb.2023.109617] |
| 4. Jiang-Hong Luo, Wan-Shuang Zou, Jing Li, Wei Liu, Jing Huang, Hu-Wei Wu, Jian-Lin Shen, Fei Li, Jia-Shuang-Wei Yuan, An-Kang Tao, Liang Gong, Jun Zhang, Xiao-Yin Wang. (2023) Untargeted serum and liver metabolomics analyses reveal the gastroprotective effect of polysaccharide from Evodiae fructus on ethanol-induced gastric ulcer in mice. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, [PMID:36731690] [10.1016/j.ijbiomac.2023.123481] |
| 5. Jieqing Feng, Qisheng Zhong, Ting Zhou. (2022) Online Pressure Change Focusing-Supercritical Fluid Selective Extraction Chromatography for Analyzing Chiral Drugs in Microliter-Scale Plasma Samples. ANALYTICAL CHEMISTRY, [PMID:36356211] [10.1021/acs.analchem.2c03892] |
| 6. Shiqi Duan, Yan Jia, Zhihang Zhu, Lancheng Wang, Peng Xu, Youmei Wang, Bin Di, Chi Hu. (2022) Induction of CYP450 by illicit drugs: Studies using an in vitro 3D spheroidal model in comparison to animals. TOXICOLOGY LETTERS, [PMID:35914676] [10.1016/j.toxlet.2022.07.815] |
| 7. Xiaoke Zheng, Hanyu Yang, Lan Qin, Siqian Wang, Lei Xie, Lu Yang, Weimin Kong, Liang Zhu, Li Liu, Xiaodong Liu. (2021) Bile Duct Ligation Upregulates Expression and Function of L-Amino Acid Transporter 1 at Blood–Brain Barrier of Rats via Activation of Aryl Hydrocarbon Receptor by Bilirubin. Biomedicines, 9 (10): (1320). [PMID:34680437] [10.3390/biomedicines9101320] |
| 8. Yuanyuan Chai, Yunxia Xu, Ziyin Xia, Xin Huang, Luyong Zhang, Zhenzhou Jiang. (2021) Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats. JOURNAL OF ETHNOPHARMACOLOGY, [PMID:34390794] [10.1016/j.jep.2021.114521] |
| 9. Lu Zhao, Jie Liu, Yunfeng Bai, Feng Feng, Xiaoming Yang. (2021) Exploration of carbon dots derived from epimedium towards detecting dopamine and hydrogen peroxide. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, [PMID:] [10.1016/j.colsurfa.2021.127179] |
| 10. Liu Mingyang, Du Xuejun, Xu Ke, Yan Binwei, Fan Zaibi, Gao Zideng, Ren Xueqin. (2021) A cationic quantum dot-based ratiometric fluorescent probe to visually detect berberine hydrochloride in human blood serums. Journal of Analytical Science and Technology, 12 (1): (1-9). [PMID:] [10.1186/s40543-021-00261-x] |
| 11. Lu Wang, Yunfeng Chai, Wenquan Zhu, Yuanjiang Pan, Cuirong Sun, Su Zeng. (2017) Doubly charged trimeric cluster ions: effective in mutual chiral recognition of tadalafil and three proton pump inhibitors. ANALYST, 142 (5): (745-751). [PMID:28197557] [10.1039/C6AN02666D] |
| 12. Lili Wu, Wanping Zhong, Junjin Liu, Weichao Han, Shilong Zhong, Qiang Wei, Shuwen Liu, Lan Tang. (2015) Human microsomal cyttrochrome P450-mediated reduction of oxysophocarpine, an active and highly toxic constituent derived from Sophora flavescens species, and its intestinal absorption and metabolism in rat. FITOTERAPIA, [PMID:26045316] [10.1016/j.fitote.2015.05.021] |
| 13. Han-Ming Cui, Qiu-Yan Zhang, Jia-Long Wang, Jian-Long Chen, Yu-Ling Zhang, Xiao-Lin Tong. (2014) In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells. JOURNAL OF ETHNOPHARMACOLOGY, [PMID:25456436] [10.1016/j.jep.2014.10.018] |
| 14. Yan Xu, Weitao Yang, Zhuoyao Wu, Hui Wang, Tianming Cui, Weiwei Zeng, Yanjing Yun, Bingbo Zhang. (2024) A Chromium-Based magnetic resonance probe for in situ gastric pH imaging. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2024.154269] |
| 15. Gu Lina, Sun Ying, Bai Tingjie, Shao Sijie, Tang Shumin, Xue Panpan, Cai Wanlin, Qin Xian, Zeng Xuemei, Yan Shuangqian. (2025) Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation. JOURNAL OF NANOBIOTECHNOLOGY, 23 (1): (1-20). [PMID:40089774] [10.1186/s12951-025-03284-3] |
| 16. Zibo Xiong, Zhiwei Lai, Sanmu Li, Hua Zhang, Yongqiang Wang, Lishan Tan, Guang Yang, Zuying Xiong. (2025) Potential Kidney Risks Associated With Clinical Doses of Omeprazole: In Vivo and In Vitro Studies. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 52 (8): (e70050). [PMID:40623774] [10.1111/1440-1681.70050] |
| 17. Lifeng Niu, Lina Ding, Chunyun Lu, Feifei Zuo, Ke Yao, Shaobo Xu, Wen Li, Donghua Yang, Xia Xu. (2016) Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. JOURNAL OF ETHNOPHARMACOLOGY, [PMID:27318274] [10.1016/j.jep.2016.06.039] |
| 18. Xin Gao, Zouhua Xu, Qingxie Liu, Chenchen Yuan, Xiaowu Dong, Xiaolei Shi, Qingtian Zhu, Keyan Wu, Hongwei Xu, Jiajia Pan, Guotao Lu, Weiming Xiao, Shengfeng Wang, Yaodong Wang. (2025) Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments. Frontiers in Pharmacology, [PMID:41132534] [10.3389/fphar.2025.1673200] |
| 19. Qian Huang, Yuqian Li, Zhiliang Gao, Yiming Shao. (2025) Integrative network toxicology and experimental validation reveal novel molecular mediators of omeprazole-induced nephrotoxicity. TOXICOLOGY AND APPLIED PHARMACOLOGY, [PMID:41265761] [10.1016/j.taap.2025.117649] |
| 20. Feifei Zhao, Yizhen Zhu, Lingxiang Mao, Honghao Huang, Wei Wei, Qiangcheng Deng, Youzhi Tang, Ning Han, Zhenling Zeng. (2025) Antimicrobial Activity, Preliminary Safety, and Pharmacokinetics Assessment of 2–3: A Pleuromutilin-Derived Compound. ACS Infectious Diseases, [PMID:41332299] [10.1021/acsinfecdis.5c00727] |
| 21. Xiaojing Wei, Binjing Zhao, Xinyi Jiang, Lunli Lan, Rui Wang, Yuanyuan Li. (2026) Vladimiria souliei alleviated ethanol induced gastric ulcer through inhibition of RIP1-RIP3-MLKL necrosome activation. FITOTERAPIA, [PMID:41565122] [10.1016/j.fitote.2026.107102] |
| 22. Hang Yin, Lei Zhu, Xiaoyu Wang, Zhen Wang, Hecheng Wang, Yong Liu. (2026) Sesamin exhibits potential food–drug interactions through the inhibition of cytochrome P450s and human UDP-glucuronosyltransferases in vitro. RSC Advances, 16 (14): (12570-12578). [PMID:] [10.1039/D6RA00237D] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →